January 31, 2020

HHS and FDA Open Notice and Comment Period for Draft Importation Rule

Libby Baney and Matt Rubin co-authored an article for the National Association of Boards of Pharmacy detailing the U.S. Department of Health and Human Services' (HHS) released in December 2019. The Trump administration is working with stakeholders to iron out two pathways to presumed lower drug prices for consumers. 
Full Article
The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.